Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Oral mucositis secondary to head and neck chemoradiation displays a complex molecular
pathogenesis involving epithelial and microvascular injury, release of pro-inflammatory …

Background This study investigated the influence of oral microbial features on the trajectory
of oral mucositis (OM) in patients with squamous cell carcinoma of the head and neck …

Oral mucositis is a common radiotherapy-induced complication among nasal, oral and
laryngeal cancer (NOALC) patients. This complication leads to decreased quality of life and …

Purpose Considering the complex pathobiology of oral mucositis, especially in oral cancer
patients, the prevention and treatment of oral mucositis in patients undergoing radiotherapy …

Purpose To assess the effect of a mucoadhesive herbal medicine containing curcuminoids
and a glycerinated extract of Bidens pilosa L.(FITOPROT) in association with …

Oral mucositis (OM) is a significant complication of cancer therapy with limited management
strategies. Whilst inflammation is a central feature of destructive and ultimately ulcerative …

Recent evidence suggests that oral microbiota is a potential biomarker for oncological
clinical outcomes and oral toxicities. Currently, the literature presents a remarkable …

Oral mucositis is a common distressing complication of cancer therapy, characterised by
painful sores within the oral cavity. Current management options offer limited symptomatic …

Radiation-induced oral mucositis (RIOM) is considered to be one of the most important
public health problems today, affecting the overall well-being of millions of patients who …